1. Home
  2. News
  3. Mayne Pharma Group Ltd.
  4. Mayne Pharma announces cancellation of capital return
More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

Mayne Pharma announces cancellation of capital return

Feb 27, 2023 at 10:23 PM EST · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Feb 27, 2023 at 10:23 PM EST · 1 page · English

On 6ix: 6ix.com/news/mayne-pharma-announces-cancellation-of-capital-return

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26↗

Mayne Pharma Group Ltd. on 6ix

In the deck

  • Mayne Pharma Group — Investor Presentation (February 2023)48 slidesFeb 28, 2023

Earlier from Mayne Pharma

  • 2023 Half Year Investor PresentationFeb 27, 2023
  • 2022 Half Year Media ReleaseFeb 27, 2023
  • Mayne Pharma announces sale of US retail generics businessFeb 27, 2023
  • Mayne Pharma to restate US dermatology net revenue for FY22Feb 14, 2023
  • Mayne Pharma and Mithra announce US launch of HALOETTE, a generic version of NUVARINGJan 16, 2023

Later from Mayne Pharma

  • Update on sale of US retail generics portfolioApr 2, 2023
  • MYX completes sale of US retail generics business for US$90mApr 10, 2023
  • Mayne Pharma May 2023 market update presentationMay 9, 2023
  • MYX provides investor update & announces on market buybackMay 9, 2023
  • Preliminary Final ReportAug 30, 2023
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer